Hepatitis C virus and human T-lymphotropic virus coinfection: epidemiological, clinical, laboratory and histopathological features

被引:8
|
作者
Padua Milagres, Flavio Augusto [1 ]
Seixas Duarte, Maria Irma [2 ]
Viso, Ana Teresa [1 ]
Segurado, Aluisio Cotrim [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-05403000 Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Dept Pathol, BR-05403000 Sao Paulo, Brazil
关键词
Hepatitis C virus; Human T lymphotropic virus type 1; Human T lymphotropic virus type 2; Epidemiological studies; Discriminant analysis; HUMAN-IMMUNODEFICIENCY-VIRUS; HTLV-II INFECTIONS; DRUG-USERS; VIRAL-HEPATITIS; BLOOD-DONORS; LIVER-BIOPSY; RISK-FACTORS; SAO-PAULO; BRAZIL; TRANSMISSION;
D O I
10.1590/S0037-86822009000400001
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Twenty-four hepatitis C virus patients coinfected with human T-lymphotropic virus type 1 were compared with six coinfected with HTLV-2 and 55 with HCV alone, regarding clinical, epidemiological, laboratory and histopathological data. Fischer's discriminant analysis was applied to define functions capable of differentiating between the study groups (HCV, HCV/HTLV-1 and HCV/HTLV-2). The discriminant accuracy was evaluated by cross-validation. Alcohol consumption, use of intravenous drugs or inhaled cocaine and sexual partnership with intravenous drug users were more frequent in the HCV/HTLV-2 group, whereas patients in the HCV group more often reported abdominal pain or a sexual partner with hepatitis. Coinfected patients presented higher platelet counts, but aminotransferase and gamma-glutamyl transpeptidase levels were higher among HCV-infected subjects. No significant difference between the groups was seen regarding liver histopathological findings. Through discriminant analysis, classification functions were defined, including sex, age group, intravenous drug use and sexual partner with hepatitis. Cross-validation revealed high discriminant accuracy for the HCV group.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 50 条
  • [41] Risk of Transmission of Human T-Lymphotropic Virus Through Transplant
    Tedla, F.
    Brar, A.
    John, D.
    Sumrani, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (04) : 1123 - 1124
  • [42] Infection of defective human T-lymphotropic virus type 1
    Yuuki Hashikura
    Kazumi Umeki
    Kunihiko Umekita
    Hajime Nomura
    Akiteru Yamada
    Ikuo Yamamoto
    Hiroo Hasegawa
    Katsunori Yanagihara
    Akihiko Okayama
    Human Cell, 2017, 30 : 117 - 123
  • [43] A gorilla reservoir for human T-lymphotropic virus type 4
    LeBreton, Matthew
    Switzer, William M.
    Djoko, Cyrille F.
    Gillis, Amethyst
    Jia, Hongwei
    Sturgeon, Michele M.
    Shankar, Anupama
    Zheng, Haoqiang
    Nkeunen, Gerard
    Tamoufe, Ubald
    Nana, Ahmadou
    Diffo, Joseph Le Doux
    Tafon, Babila
    Kiyang, John
    Schneider, Bradley S.
    Burke, Donald S.
    Wolfe, Nathan D.
    EMERGING MICROBES & INFECTIONS, 2014, 3
  • [44] A case series on UCB seroprevalance of Human T-lymphotropic virus
    Seal, S.
    Mukherjee, D. N.
    Mukherjee, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 248 - 248
  • [45] HUMAN T-LYMPHOTROPIC VIRUS TYPE-II IN VIETNAM
    FUKUSHIMA, Y
    NAKASONE, T
    NAKATA, S
    PHAM, S
    DAO, DD
    KOMURO, K
    HONDA, M
    LANCET, 1994, 344 (8920): : 485 - 485
  • [46] Parkinsonism in a Patient with Human T-lymphotropic Virus 1 Myelopathy
    Afzal, Hasnain
    Kadakia, Satish
    Lev, Steven
    CUREUS, 2018, 10 (07):
  • [47] Infection of defective human T-lymphotropic virus type 1
    Hashikura, Yuuki
    Umeki, Kazumi
    Umekita, Kunihiko
    Nomura, Hajime
    Yamada, Akiteru
    Yamamoto, Ikuo
    Hasegawa, Hiroo
    Yanagihara, Katsunori
    Okayama, Akihiko
    HUMAN CELL, 2017, 30 (02): : 117 - 123
  • [48] Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes
    Rotman, Yaron
    Liang, T. Jake
    JOURNAL OF VIROLOGY, 2009, 83 (15) : 7366 - 7374
  • [49] SEXUAL TRANSMISSION OF SIMIAN T-LYMPHOTROPIC VIRUS TYPE-I - A MODEL OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION
    LAZO, A
    BAILER, RT
    LAIRMORE, MD
    YEE, JAL
    ANDREWS, J
    STEVENS, VC
    BLAKESLEE, JR
    LEUKEMIA, 1994, 8 : S222 - S226
  • [50] Repurposing Antiviral Drugs Against human T-lymphotropic virus
    Aneaus, Sheikh
    Buch, Khuban
    Shivakumar, M. S.
    Induja, M. S.
    Mulasseri, Sileesh
    Tekam, Manish Kumar
    Arjumand, Tahera
    CURRENT SCIENCE, 2024, 126 (04):